Mimedx Group Inc
NASDAQ:MDXG
| Market Cap (Intraday) | 868.71M |
| Current PE | 10.01 |
| Forward PE | 21.15 |
| 2yr Forward PE | 18.42 |
| 10-Day MA | $5.71 |
| 50-Day MA | $6.19 |
| 200-Day MA | $7.18 |
Mimedx Group Inc Stock, NASDAQ:MDXG
1775 West Oak Commons Court NE, 1775 West Oak Commons Court NE, Marietta, Georgia 30062
United States of America
Phone: +1.770.651.9100
Number of Employees: 895
Description
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.